COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
Articles on Multiple Sclerosis
Displaying 21 - 40 of 58 articles
Getting glandular fever between ages 11 and 19 is associated with a significantly increased risk of getting MS after age 20.
Infections diagnosed in a hospital between ages 11 and 19 are associated with an increased risk of multiple sclerosis.
Our gut microbes play a key role in sending and receiving signals that influence the brain.
This antibody protects patients from viruses, even while on immunosuppressant drugs.
Obesity in young people today may contribute up to 14% of overall risk of multiple sclerosis in 2035.
Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
Our research has found a way of switching immune system cells from attacking to protecting.
When people lose their speech, they can stop working and friends can drift away. Here’s what we can do to help them get the rehabilitation they need.
A promising new approach to treating MS tricks defective immune cells into thinking they are attacking the body, when they are in fact being attacked themselves.
A doctor with MS who experimented with diet and other treatments has experienced a slowing of her decline – now she’s researching why it happened.
When nerve cells in the brain pass electrical signals to each other, they create tiny electric fields that can be sensed from outside the skull.
Biological research can inspire technological innovation. Also, software that models computer networks can inform health care for patients with neurological disorders.
Young women are disproportionately affected by multiple sclerosis, a disease where the body attacks the brain, scrambling communication to the rest of the body. Here’s what we know about the causes.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
All multiple sclerosis sufferers have stem cells with the potential to heal them, but scientists are only just figuring out how to kick them into action.
Women have evolved to have stronger immunity than men. But this comes with downsides -
women are more likely to have autoimmune diseases due to their “reactive” immune systems.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
There are many anecdotal reports indicating cannabis’ beneficial effects for treating MS symptoms, but research with cannabis is difficult to do.
Fingolimod is a drug used to treat multiple sclerosis (MS), an autoimmune disease. It is an immunomodulator, which means it works by suppressing the immune system.
Top contributors
-
Honorary Professor, Epidemiology, UCL
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Electrical Engineering and Bioengineering, Tau Beta Pi Eminent Engineer, University of South Florida
-
Postdoctoral Associate in Neuroscience, University of Florida
-
Assistant Professor, Department of Clinical Neuroscience, Karolinska Institutet
-
Senior lecturer in Immunology, University of Exeter
-
MB/PhD Candidate, University of Cambridge
-
Adjunct professor, Department of Health Policy & Management, George Washington University
-
Research Assistant, University of Bristol
-
Laboratory Head, Florey Institute of Neuroscience and Mental Health
-
Professor in Occupational Therapy, Department of Health Studies, Royal Holloway, University of London
-
Post-doctoral Researcher, Harvard University
-
Professor, Molecular Immunology, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor; Director, Menzies Research Institute, University of Tasmania
-
Clinical Associate Professor, University of Nottingham